These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 3132384

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
    Kallings I, Bengtsson S, Christensen P, Holm SE, Lind L, Kalin M.
    Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.
    Biedenbach DJ, Jones RN, Lewis MT, Croco MA, Barrett MS.
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755
    [Abstract] [Full Text] [Related]

  • 26. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods.
    Morrissey I, Robbins M, Viljoen L, Brown DF.
    J Antimicrob Chemother; 2005 Feb; 55(2):200-8. PubMed ID: 15649996
    [Abstract] [Full Text] [Related]

  • 27. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Shimizu Y, Terai T, Inoue H, Nakadate T, Ito C, Yoshida T, Ohno I, Tanno Y, Arakawa M, Igarashi K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Nakata K, Nakatani T, Inagawa H, Kusano N.
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [Abstract] [Full Text] [Related]

  • 28. Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983.
    Forsgren A, Walder M.
    Acta Otolaryngol Suppl; 1984 Jul; 407():43-9. PubMed ID: 6437134
    [Abstract] [Full Text] [Related]

  • 29. In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program.
    Flamm RK, Rhomberg PR, Sader HS.
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971877
    [Abstract] [Full Text] [Related]

  • 30. In vitro activity of the new ketolide ABT-773 against community acquired respiratory tract isolates and Viridans Streptococci.
    Casellas JM, Tomé G, Visser M, Gliosca L.
    Diagn Microbiol Infect Dis; 2002 Feb; 42(2):107-12. PubMed ID: 11858905
    [Abstract] [Full Text] [Related]

  • 31. In-vitro antimicrobial activity of 7432-S (SCH39720) against commonly isolated respiratory tract pathogens.
    Jones RN, Barry AL.
    J Antimicrob Chemother; 1988 Sep; 22(3):387-9. PubMed ID: 3141348
    [No Abstract] [Full Text] [Related]

  • 32. Postantibiotic effect and postantibiotic sub-mic effect of dirithromycin and erythromycin against respiratory tract pathogenic bacteria.
    Dornbusch K, Olofsson C, Holm S.
    APMIS; 1999 May; 107(5):505-13. PubMed ID: 10335955
    [Abstract] [Full Text] [Related]

  • 33. Antibacterial profile of flurithromycin, a new macrolide.
    Saverino D, Debbia EA, Pesce A, Lepore AM, Schito GC.
    J Antimicrob Chemother; 1992 Sep; 30(3):261-72. PubMed ID: 1452490
    [Abstract] [Full Text] [Related]

  • 34. In-vitro activity of cefodizime against respiratory pathogens.
    Wise R, Andrews JM, Ashby JP.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():9-12. PubMed ID: 2127417
    [Abstract] [Full Text] [Related]

  • 35. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2012: General view of the pathogens' antibacterial susceptibility.
    Yanagihara K, Watanabe A, Aoki N, Matsumoto T, Yoshida M, Sato J, Wakamura T, Sunakawa K, Kadota J, Kiyota H, Iwata S, Kaku M, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Takeuchi K, Takeda H, Ikeda H, Miki M, Nakanowatari S, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Morino E, Takasaki J, Mezaki K, Chonabayashi N, Tanaka C, Sugiura H, Goto H, Saraya T, Kurai D, Katono Y, Inose R, Niki Y, Takuma T, Kudo M, Ehara S, Sato Y, Tsukada H, Watabe N, Honma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Seki M, Hamaguchi S, Toyokawa M, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Nakamura T, Mikasa K, Kasahara K, Ui K, Fukuda S, Nakamura A, Morimura M, Yamashita M, Takesue Y, Wada Y, Sugimoto K, Kusano N, Nose M, Mihara E, Kuwabara M, Doi M, Watanabe Y, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Ota T, Fujita M, Honda J, Hiramatsu K, Aoki Y, Fukuoka M, Magarifuchi H, Nagasawa Z, Kaku N, Fujita J, Higa F, Tateyama M.
    J Infect Chemother; 2017 Sep; 23(9):587-597. PubMed ID: 28669567
    [Abstract] [Full Text] [Related]

  • 36. Preparation and in vitro antibacterial activity of 9-O-glycosyloxime derivatives of erythromycin A, a new class of macrolide antibiotics.
    Grandjean C, Lukacs G.
    J Antibiot (Tokyo); 1996 Oct; 49(10):1036-43. PubMed ID: 8968398
    [Abstract] [Full Text] [Related]

  • 37. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2004)].
    Goto H, Takeda H, Kawai S, Watanabe T, Okazaki M, Shimada K, Nakano K, Yokouchi H, Ikemoto H, Mori T, Igari J, Oguri T, Yamamoto M, Inoue H, Nakadate T, Suwabe A, Ashino Y, Gejyo F, Okada M, Aoki N, Kitamura N, Suzuki Y, Karasawa Y, Kudo K, Kobayashi N, Tanaka T, Sumitomo M, Matsushima T, Oka M, Niki Y, Suga M, Tosaka M, Kohno S, Hirakata Y, Kondou A, Matsuda J, Nakano M, Nasu M, Hiramatsu K, Oikawa S.
    Jpn J Antibiot; 2006 Oct; 59(5):323-54. PubMed ID: 17180803
    [Abstract] [Full Text] [Related]

  • 38. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014].
    Sun H, Chen L, Chen X, Jia X, Li N, Liu W, Tong H, Xiang R, Zhang F, Zhao H, Zhang J, Xu Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jan; 39(1):30-7. PubMed ID: 26792053
    [Abstract] [Full Text] [Related]

  • 39. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q, Xu Y, Chen M, Wang H, Sun H, Hu Y, Zhang R, Duan Q, Zhuo C, Cao B, Liu Y, Yu Y, Sun Z, Chu Y.
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [Abstract] [Full Text] [Related]

  • 40. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
    Sun HL, Yang QW, Xu YC, Wang H, Xie XL, Chen MJ, Zhang XZ, Liu Y, Ye HF, Sun ZY, Duan Q, Ni YX, Yu YS, Zhao WS, He L, Wang J, Ji P, Liu PP, Zhang LX.
    Zhonghua Yi Xue Za Zhi; 2009 Nov 17; 89(42):2983-7. PubMed ID: 20137709
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.